Big Biotech is here — and it’s starting to look a lot like Big Pharma
By Meghana Keshavan,
STAT News
| 06. 06. 2016
Move over, Big Pharma. Big Biotech is coming for you.
As drug developers and investors from around the world gather in San Francisco this week for the annual BIO International Convention, a new look at the biotech industry shows the biggest players are starting to behave more and more like pharmaceutical giants.
There are 17 biotech companies in the US that generate more than $500 million per year in revenue. And they’re increasingly focused on buying innovative new products through mergers and acquisitions, rather than developing them in house, according to a report from EY (formerly Ernst & Young) released Monday.
“We now have multiple big biotechs that have the financial firepower to compete with big pharma,” said Ellen Licking, a senior analyst in EY’s life sciences practice.
Continue reading on STAT News
Image via Flickr
Related Articles
By Alex Aylward, Daniel J. Fairbanks, Maria Kiladi, and Gregory Radick , Heredity | 04.20.2026
Genetics and eugenics co-evolved at the beginning of the twentieth century and remained associated through the 1940s and beyond. Early geneticists were far from unanimous in their views on eugenics; some avidly supported the movement, whereas others openly opposed it...
By Carly Mallenbaum and Alex Golden, Axios | 04.08.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations that can determine everything from whether agreements are legally binding to who is recognized as a parent at birth.
Why it matters: More Americans...
By Mary Hartnett, WFYI | 03.30.2026
"1907 Indiana Eugenics Law" via Wikimedia Commons | CC by-SA 4.0
Indiana was the first government in the world to pass a eugenic sterilization law. The state sterilized 2,500 people from 1907-to-1974. Indiana apologized for implementing the program...
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
